Related Experiment Video
Updated: Jun 17, 2026
07:16
Thermal Ablation for the Treatment of Abdominal Tumors
Published on: March 7, 2011
Renal ablative therapy: radiofrequency ablation and cryoablation.
Jay D Raman1, David W Hall, Jeffrey A Cadeddu
1Division of Urology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
Journal of Surgical Oncology
|December 18, 2009
Summary
Thermal ablation offers similar cancer control to surgery for small kidney tumors, with less patient harm. This minimally invasive approach is becoming crucial for managing renal masses, especially in older or sicker patients.
Area of Science:
- Urology
- Oncology
- Minimally Invasive Surgery
Background:
- Cross-sectional imaging advances have increased small renal mass diagnoses.
- Surgical extirpation was the traditional management, but thermal ablation is emerging.
- Ablation presents a less morbid alternative to traditional surgery.
Purpose of the Study:
- To evaluate thermal ablation as a primary therapy for small renal masses.
- To compare oncologic outcomes and patient morbidity between ablation and extirpation.
- To highlight the growing role of ablation in renal mass management.
Main Methods:
- Review of contemporary series and outcomes data.
- Comparison of oncologic control rates between thermal ablation and surgical extirpation.
- Assessment of patient morbidity associated with both treatment modalities.
Main Results:
- Ablative procedures demonstrate comparable oncologic outcomes to surgical extirpation.
- Thermal ablation significantly minimizes patient morbidity compared to extirpation.
- The incidence of small renal masses is rising, particularly in elderly and comorbid populations.
Conclusions:
- Thermal ablation is a viable and effective primary treatment for small renal masses.
- Ablation offers a favorable risk-benefit profile, especially for high-risk patients.
- Minimally invasive ablation is poised to become a cornerstone in renal mass management strategies.
